SCICLONE PHARMACEUTICALS INC 4
4 · SCICLONE PHARMACEUTICALS INC · Filed Nov 15, 2016
Insider Transaction Report
Form 4
Chern Carey
General Counsel
Transactions
- Award
Incentive Stock Option (right to buy)
2016-11-14+38,644→ 38,644 totalExercise: $10.35Exp: 2026-11-14→ Common Stock (38,644 underlying) - Award
Non-Qualified Stock Option (right to buy)
2016-11-14+41,356→ 41,356 totalExercise: $10.35Exp: 2026-11-14→ Common Stock (41,356 underlying) - Award
Restricted Stock Unit
2016-11-14+30,000→ 30,000 totalExercise: $0.00→ Common Stock (30,000 underlying)
Footnotes (3)
- [F1]Granted under the Issuer's 2015 Equity Incentive Plan.
- [F2]25% of such shares vest on October 24, 2017 and 2.0833% vests each month thereafter provided that the Reporting Person continues to be employed by the Issuer.
- [F3]Vesting for such RSUs will occur 25% on October 24, 2017, 25% on October 24, 2018, 25% on October 24, 2019, and 25% on October 24, 2020, or, in the discretion of the Company, such later date on which the sale of the Stock to be issued in settlement of such Unit would not violate the Trading Compliance Policy.